BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 6768438)

  • 21. Adverse reactions to D-penicillamine after gold toxicity.
    Dodd MJ; Griffiths ID; Thompson M
    Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?
    Menard HA; Mathieu JP; de Medicis R; Lussier A
    J Rheumatol; 1979; 6(2):156-62. PubMed ID: 110929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some aspects of slow-acting drugs in rheumatoid arthritis.
    Ansell BM
    Agents Actions Suppl; 1979; (5):111-9. PubMed ID: 294130
    [No Abstract]   [Full Text] [Related]  

  • 24. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract]   [Full Text] [Related]  

  • 25. Gold in the treatment of rheumatoid arthritis -- why, when and how?
    Jessop JD
    J Rheumatol Suppl; 1979; 5():12-7. PubMed ID: 114641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of response to systematised drug therapy in rheumatoid arthritis in Indians.
    Malaviya AN; Khan KM; Tiwari SC
    Indian J Med Res; 1983 May; 77():686-96. PubMed ID: 6413397
    [No Abstract]   [Full Text] [Related]  

  • 27. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The place of levamisole in the armamentarium for rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1978; 4():149-52. PubMed ID: 282445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
    Farr M; Kitas G; Bacon PA
    Clin Rheumatol; 1988 Jun; 7(2):242-8. PubMed ID: 2901303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems of basic therapy of rheumatic diseases with chloroquine, gold and D-penicillamine].
    Meyer W; Weyerbrock W
    Internist (Berl); 1979 Sep; 20(9):426-32. PubMed ID: 115810
    [No Abstract]   [Full Text] [Related]  

  • 33. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term (four year) clinical trial with tenoxicam and basis therapy in patients suffering from rheumatoid arthritis.
    Lalos J; Tsachalos P; Gallis L
    Scand J Rheumatol Suppl; 1989; 80():67-70. PubMed ID: 2512637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
    [No Abstract]   [Full Text] [Related]  

  • 38. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
    Dixon JS; Greenwood M; Bird HA
    Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is gold necessary in so called chrysotherapy?
    Munthe E; Jellum E
    Scand J Rheumatol Suppl; 1983; 51():46-51. PubMed ID: 6426053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.